~~<i id='07A35F4457'><strike id='07A35F4457'><tt id='07A35F4457'><pre id='07A35F4457'></pre></tt></strike></i>~~

Home» leisure time» knowledge

knowledge

author：comprehensive 2025-09-28 19:10:33 Page View：69536

Hiram Secrist (left), who has Duchenne muscular dystrophy, with his mother, Kristen Secrist (center), and his grandmother, Terrie Jordan. Courtesy Secrist family

In mid-July, Kristen Secrist hopped on a call with her 5-year-old son’s doctor, who had urgent news: The first gene therapy had been approved for Duchenne muscular dystrophy. Her son, Hiram, would be a perfect candidate — if, she added, they could get him dosed in time.

The treatment was approved only for 4- and 5-year-olds. Hiram turned 6 in three weeks.

“Oh, crap,” Secrist said to herself.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： PrEP can help anyone prevent HIV. Why do so few people take it?
Next article： Heart attack and stroke risk calculators need revising

leisure time

How one medical school became remarkably diverse

ThefirstclassattheUniversityofCalifornia,Davismedicalschool,in1972,waspredominantlywhiteandmale.Chri

FAMU bans football players from facility after release of rap video shot in team's locker room

FILE-AFloridaA&MhelmetsportstheRattlerslogobeforeanNCAAcollegefootballgameagainstNorthCarolinainChap

Continuity nursing helped my family in our darkest PICU moments

EssayauthorSarahMcCarthycuddleswithherdaughterMolly.CourtesySarahMcCarthyTheventilatoralarmwokemeat3

SAMSHA loosens regulations on methadone treatment centers

AdoseofmethadoneKevinD.Liles/APThefederalgovernmentisunveilingnewregulationsmeanttomodernizemethadon